Skip to main content
. Author manuscript; available in PMC: 2005 Oct 17.
Published in final edited form as: Am J Addict. 2004;13(Suppl 1):S42–S66. doi: 10.1080/10550490490440807

TABLE 2.

Overview of Participating NIDA CTN-0002 Outpatient Programs (N = 157)

Site (number randomized) Location Type Program Involved in Study Overall Services Provided* Medications Historically Used for Opioid Dependence Treatment
Addiction Research and Treatment Corporation (n = 30) Brooklyn, NY Public, non-profit opiate treatment program (OTP) Large, outpatient OTP C, O Methadone
Aegis Medical Systems (n = 29) Oxnard, CA Public, for-profit organization of licensed OTPs Large, outpatient OTP C, O Methadone, LAAM, naltrexone
Bellevue Hospital (n = 20) New York, NY Public, non-profit, hospital-based substance abuse service with OTP Large, outpatient OTP C, O, IOP Methadone
Kaiser-Permanente Northwest (n = 19) Portland, OR Non-profit HMO Department of Addiction Medicine within a large primary care setting C, O, IOP, AD Clonidine
Mercer Trenton Addiction Science Center/Robert Wood Johnson Medical School (n = 27) Trenton, NJ Public, non-profit, university-based with OTP Outpatient OTP C, O, IOP, AD Methadone
Midtown Community Mental Health Center (n = 32) Indianapolis, IN Community Mental Health Center, public, non-profit, integrated mental health and addictions with OTP Outpatient Detoxification Clinic at Wishard Hospital C, O, IOP, A, AD, IR, D, F Methadone, LAAM, non-narcotic
*

IOP = intensive outpatient; O = outpatient; IR = intensive residential; LTR = long-term residential; A = aftercare; AD = ambulatory detoxification; D = day treatment, C = comprehensive service; F = family services.

HHS Vulnerability Disclosure